Clinical Impact of Compensatory Hyperinflation of the Nontreated Adjacent Lobe After Bronchoscopic Lung Volume Reduction with Valves

References

• Sciurba FC, Ernst A, Herth FJF, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244. doi:10.1056/NEJMoa0900928
   PubMed Web of Science ®Google Scholar
• Gompelmann D, Herth FJF, Slebos DJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–491. doi:10.1159/000360641
   PubMed Web of Science ®Google Scholar
• Koster TD, Klooster K, Ten Hacken NHT, van Dijk M, Slebos DJ. Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management. Expert Rev Respir Med. 2020;14(12):1235–1247. doi:10.1080/17476348.2020.1813571
   PubMed Web of Science ®Google Scholar
• Davey C, Zoumot Z, Jordan S, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066–1073. doi:10.1016/S0140-6736(15)60001-0
   PubMed Web of Science ®Google Scholar
• Kemp SV, Slebos DJ, Kirk A, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12):1535–1543. doi:10.1164/rccm.201707-1327OC
   PubMed Web of Science ®Google Scholar
• Valipour A, Slebos DJ, Herth F, et al. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med. 2016;194(9):1073–1082. doi:10.1164/rccm.201607-1383OC
   PubMed Web of Science ®Google Scholar
• Klooster K, ten Hacken NHT, Hartman JE, Kerstjens HAM, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335. doi:10.1056/NEJMoa1507807
   PubMed Web of Science ®Google Scholar
• Gompelmann D, Heinhold T, Rötting M, et al. Long-term follow up after endoscopic valve therapy in patients with severe emphysema. Ther Adv Respir Dis. 2019;13:175346661986610. doi:10.1177/1753466619866101
   Web of Science ®Google Scholar
• Brown MS, Kim HJ, Abtin FG, et al. Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. Eur Radiol. 2012;22(7):1547–1555. doi:10.1007/s00330-012-2393-6
   PubMed Web of Science ®Google Scholar
• Coxson HO, Fauerbach PVN, Storness-Bliss C, et al. Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J. 2008;32(6):1443–1450. doi:10.1183/09031936.00056008
   PubMed Web of Science ®Google Scholar
• Welling JBA, Hartman JE, van Rikxoort EM, et al. Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema. Respirology. 2018;23(3):306–310. doi:10.1111/resp.13178
   PubMed Web of Science ®Google Scholar
• Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111–124. doi:10.1081/COPD-200053377
   PubMedGoogle Scholar
• Hartman JE, ten Hacken NHT, Klooster K, Boezen HM, de Greef MHG, Slebos DJ. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J. 2012;40(5):1137–1141. doi:10.1183/09031936.00219111
   PubMed Web of Science ®Google Scholar
• Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010;91(2):221–225. doi:10.1016/j.apmr.2009.10.017
   PubMed Web of Science ®Google Scholar
• Copay AG, Subach BR, Glassman SD, Polly DW, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 2007;7(5):541–546. doi:10.1016/j.spinee.2007.01.008
   PubMed Web of Science ®Google Scholar
• Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. Am J Respir Crit Care Med. 2002;165(1):34–40. doi:10.1164/ajrccm.165.1.2101149
   PubMed Web of Science ®Google Scholar
• Fessler HE, Scharf SM, Ingenito EP, McKenna RJ, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc. 2008;5(4):416–420. doi:10.1513/pats.200708-117ET
   PubMedGoogle Scholar
• Valipour A, Herth FJF, Burghuber OC, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–396. doi:10.1183/09031936.00133012
   PubMed Web of Science ®Google Scholar
• Gompelmann D, Kontogianni K, Schuhmann M, Eberhardt R, Heussel C, Herth F. The minimal important difference for target lobe volume reduction after endoscopic valve therapy. Int J Chron Obstruct Pulmon Dis. 2018;13:465–472. doi:10.2147/COPD.S152029
   PubMed Web of Science ®Google Scholar
• Valipour A, Slebos DJ, de Oliveira HG, et al. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema–potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–521. doi:10.1159/000360642
   PubMed Web of Science ®Google Scholar
• Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi:10.1016/j.jclinepi.2007.03.012
   PubMed Web of Science ®Google Scholar
• Eberhardt R, Herth FJF, Radhakrishnan S, Gompelmann D. Comparing clinical outcomes in upper versus lower lobe endobronchial valve treatment in severe emphysema. Respiration. 2015;90(4):314–320. doi:10.1159/000437358
   PubMed Web of Science ®Google Scholar